# A Study of Dulaglutide in Chinese Participants

> **NCT01667900** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 58 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Healthy Volunteers

## Interventions

- **DRUG:** Dulaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01667900
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2016-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667900, "A Study of Dulaglutide in Chinese Participants". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01667900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*